Zaloguj się

Gotowe bibliografie tematyczne / Immunoglobulin G/pharmacology / Artykuły w czasopismach

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Immunoglobulin G/pharmacology.

Artykuły w czasopismach na temat „Immunoglobulin G/pharmacology”

Autor: Grafiati

Data publikacji: 2 czerwca 2025

Data aktualizacji: 31 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Immunoglobulin G/pharmacology”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Красавцев, Е. Л., and М. В. Подоляко. "Detection Rate of Immunoglobulins G to Toxocar Antigens in the Republic of Belarus." Педиатрия. Восточная Европа, no. 3 (November 3, 2022): 319–24. http://dx.doi.org/10.34883/pi.2022.10.3.003.

Pełny tekst źródła

Streszczenie:

Цель. Изучить частоту выявления иммуноглобулинов G к антигенам токсокар у детей в различных регионах Республики Беларусь, различного возраста, пола.Материалы и методы. Анализ на иммуноглобулины G к антигенам токсокар был взят у 11 541 ребенка. Сравнение частоты выявления иммуноглобулинов G к антигенам токсокар у детей, проживающих в различных регионах Республики Беларусь, различного пола, возраста было произведено методами непараметрической статистики (таблицы 2×2, критерий χ2).Результаты. В результате исследования 11 541 ребенка иммуноглобулины G к антигенам токсокар были выявлены у 1153 чело

Style APA, Harvard, Vancouver, ISO itp.

2

Liu, Di, Jing You, Yexin Liu, et al. "Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy." International Immunopharmacology 66 (January 2019): 13–18. http://dx.doi.org/10.1016/j.intimp.2018.10.044.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Jurhar-Pavlova, Maja, Aleksandar Petlichkovski, Dejan Trajkov, et al. "Influence of the elevated ambient temperature on immunoglobulin G and immunoglobulin G subclasses in sera of Wistar rats." Vojnosanitetski pregled 60, no. 6 (2003): 657–61. http://dx.doi.org/10.2298/vsp0306657j.

Pełny tekst źródła

Streszczenie:

The aim of our research was to examine changes in the immune system of the rats influenced by the elevated ambient temperature. Male Wistar rats were divided, into 2 groups and housed at 20 ? 2?C (n=64, control group) and 35 ? 1?C (n=74, experimental group), during precise timing of 1, 4, 7, 14, 21, and 30 days. All the animals were given food and water ad libitum, and were lighted during 12 hours per day. We have measured IgG, IgG1, IgG2a, IgG2b and IgG2c. The obtained results showed significant elevation in the level of IgG after 4 and 7 days (+32%), IgG2a after 7th (+88%), 14th and 21nd day

Style APA, Harvard, Vancouver, ISO itp.

4

Kinoshita, Makiko, and A. Catharine Ross. "Quantitative Analysis of Immunoglobulin G Subclasses in the Rat." Journal of Immunoassay 14, no. 3 (1993): 149–66. http://dx.doi.org/10.1080/15321819308019846.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Buttmann, Mathias, Srini Kaveri, and Hans-Peter Hartung. "Polyclonal immunoglobulin G for autoimmune demyelinating nervous system disorders." Trends in Pharmacological Sciences 34, no. 8 (2013): 445–57. http://dx.doi.org/10.1016/j.tips.2013.05.009.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Voltersvik, Pål, Grethe Albrektsen, Elling Ulvestad, Anne Dyrhol-Riise, Birger Sørensen, and Birgitta Åsjö. "Changes in Immunoglobulin Isotypes and Immunoglobulin G (IgG) Subclasses During Highly Active Antiretroviral Therapy." JAIDS Journal of Acquired Immune Deficiency Syndromes 34, no. 4 (2003): 358–67. http://dx.doi.org/10.1097/00126334-200312010-00002.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Miura, Yoko, Masafumi Uematsu, Mugen Teshima, et al. "Injection Site and Pharmacokinetics After Intravitreal Injection of Immunoglobulin G." Journal of Ocular Pharmacology and Therapeutics 27, no. 1 (2011): 35–41. http://dx.doi.org/10.1089/jop.2010.0112.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Ghosh, Asish Kumar, Olfert Landt, Mahmuda Yeasmin, et al. "Clinical Presentation of COVID-19 and Antibody Responses in Bangladeshi Patients Infected with the Delta or Omicron Variants of SARS-CoV-2." Vaccines 10, no. 11 (2022): 1959. http://dx.doi.org/10.3390/vaccines10111959.

Pełny tekst źródła

Streszczenie:

The clinical presentation of COVID-19 and the specific antibody responses associated with SARS-CoV-2 variants have not been investigated during the emergence of Omicron variants in Bangladesh. The Delta and Omicron variants were identified by post-PCR melting curve analysis of the spike (S) protein receptor binding domain amplicons. Anti-S-protein immunoglobulin-G anti-nucleocapsid (N)-protein immunoglobulin-G and immunoglobulin-A levels were measured by ELISA. The Delta variant was found in 40 out of 40 (100%) SARS-CoV-2 RT-PCR positive COVID-19 patients between 13 September and 23 October 20

Style APA, Harvard, Vancouver, ISO itp.

9

JARLØV, A. E., P. MUNKHOLM, P. NORDBLAD SCHMIDT, E. LANGHOLZ, B. FABER VESTERGAARD, and R. MøLSKOV BECH. "Treatment of active distal ulcerative colitis with immunoglobulin G enemas." Alimentary Pharmacology & Therapeutics 7, no. 5 (2007): 561–65. http://dx.doi.org/10.1111/j.1365-2036.1993.tb00133.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Dunsmore, Kimberly P. "Intravenous Immunoglobulin G Therapy in Fetal and Neonatal Alloimmune Thrombocytopenia." BioDrugs 8, no. 4 (1997): 265–72. http://dx.doi.org/10.2165/00063030-199708040-00003.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Akatsuka, Masayuki, Yoshiki Masuda, Hiroomi Tatsumi, and Tomoko Sonoda. "Efficacy of Intravenous Immunoglobulin Therapy for Patients With Sepsis and Low Immunoglobulin G Levels: A Single-Center Retrospective Study." Clinical Therapeutics 44, no. 2 (2022): 295–303. http://dx.doi.org/10.1016/j.clinthera.2021.12.008.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Markovic-Sovtic, Gordana, Borisav Jankovic, Zorica Rakonjac, Jelena Martic, and Katarina Pejic. "Use of intravenous immunoglobulin in neonates with haemolytic disease and immune thrombocytopenia." Vojnosanitetski pregled 70, no. 11 (2013): 1029–33. http://dx.doi.org/10.2298/vsp1311029m.

Pełny tekst źródła

Streszczenie:

Background/Aim. Intravenous immunoglobulin is a blood product made of human polyclonal immunoglobulin G. The mode of action of intravenous immunoglobulin is very complex. It is indicated in treatment of neonatal immune thrombocytopenia and haemolytic disease of the newborn. The aim of the study was to present our experience in the use of intravenous immunoglobulin in a group of term neonates. Methods. We analysed all relevant clinical and laboratory data of 23 neonates who recieved intravenous immunoglobulin during their hospitalization in Neonatal Intensive Care Unit of Mother and Child Healt

Style APA, Harvard, Vancouver, ISO itp.

13

Sechan, Ferdyansyah, Katherine Loens, Herman Goossens, Margareta Ieven, and Lia van der Hoek. "Endemic Human Coronavirus-Specific Nasal Immunoglobulin A and Serum Immunoglobulin G Dynamics in Lower Respiratory Tract Infections." Vaccines 12, no. 1 (2024): 90. http://dx.doi.org/10.3390/vaccines12010090.

Pełny tekst źródła

Streszczenie:

Endemic human coronaviruses (HCoV) NL63, 229E, OC43, and HKU1 cause respiratory infection. Following infection, a virus-specific serum antibody rise is usually observed, coinciding with recovery. In some cases, an infection is not accompanied by an immunoglobulin G (IgG) antibody rise in serum in the first month after HCoV infection, even though the infection has cleared in that month and the patient has recovered. We investigated the possible role of nasal immunoglobulin A (IgA). We measured spike (S) and nucleocapsid (N)-specific nasal IgA during and after an HCoV lower respiratory tract inf

Style APA, Harvard, Vancouver, ISO itp.

14

Li, Hong, Yanhui Lu, Longzhu Piao, et al. "Folate-Immunoglobulin G as an Anticancer Therapeutic Antibody." Bioconjugate Chemistry 21, no. 5 (2010): 961–68. http://dx.doi.org/10.1021/bc900545h.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Corona, Alberto, Giuseppe Richini, Sara Simoncini, et al. "Treating Critically Ill Patients Experiencing SARS-CoV-2 Severe Infection with Ig-M and Ig-A Enriched Ig-G Infusion." Antibiotics 10, no. 8 (2021): 930. http://dx.doi.org/10.3390/antibiotics10080930.

Pełny tekst źródła

Streszczenie:

SARS-CoV-2 in patients who need intensive care unit (ICU) is associated with a mortality rate ranging from 10 to 40–45%, with an increase in morbidity and mortality in presence of sepsis. We hypothesized that IgM and IgA enriched immunoglobulin G may support the sepsis-related phase improving patient outcome. We conducted a retrospective case–control study on 47 consecutive patients admitted to our ICU. At the time of admission, patients received anticoagulants (heparin sodium) together with the standard supportive treatment. We decided to add IgM and IgA enriched immunoglobulin G to the stand

Style APA, Harvard, Vancouver, ISO itp.

16

&NA;. "Intravenous immunoglobulin G makes antenatal therapy possible in neonatal alloimmune thrombocytopenia." Drugs & Therapy Perspectives 11, no. 10 (1998): 6–8. http://dx.doi.org/10.2165/00042310-199811100-00002.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Girkontaite, Irute, Margarita Leckiene, and Mykolas Mauricas. "Immunochemical Study of Human Immunoglobulin G Fc Region." Cancer Biotherapy and Radiopharmaceuticals 11, no. 1 (1996): 87–96. http://dx.doi.org/10.1089/cbr.1996.11.87.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Winward, Doreen Bianchi, and Mary T. Brophy. "Acute Renal Failure After Administration of Intravenous Immunoglobulin: Review of the Literature and Case Report." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 15, no. 6 (1995): 765–72. http://dx.doi.org/10.1002/j.1875-9114.1995.tb02894.x.

Pełny tekst źródła

Streszczenie:

Within in last 7 years the literature has published several reports of acute renal failure after the administration of intravenous immunoglobulin. Review of these cases finds that all occurrences in the United States except one involved a sucrose‐containing immunoglobulin preparation, leading to the suspicion that sucrose may be the cause of the renal failure. Further investigation found that approximately 50 years ago, when sucrose was used as an osmotic diuretic, investigators reported acute renal failure in humans after intravenous infusions of 50 g or more. A patient at our institution dev

Style APA, Harvard, Vancouver, ISO itp.

19

Drabick, Joseph J., Apurba K. Bhattacharjee, David L. Hoover, et al. "Covalent Polymyxin B Conjugate with Human Immunoglobulin G as an Antiendotoxin Reagent." Antimicrobial Agents and Chemotherapy 42, no. 3 (1998): 583–88. http://dx.doi.org/10.1128/aac.42.3.583.

Pełny tekst źródła

Streszczenie:

ABSTRACT Polymyxin B (PMB) is a cyclic decapeptide antibiotic which also binds and neutralizes endotoxin. Unfortunately, PMB can be considerably nephrotoxic at clinically utilized doses, thereby limiting its utility as a therapeutic antiendotoxin reagent. We sought to change the pharmacokinetics and toxicity profile of PMB by covalently linking it to a human immunoglobulin G (IgG) carrier. Conjugates of PMB with IgG were prepared by EDAC [1-ethyl-3-(3-dimethylaminopropyl) carbodiimide]-mediated amide formation. Analysis by dot enzyme-linked immunosorbent assay with an anti-PMB monoclonal antib

Style APA, Harvard, Vancouver, ISO itp.

20

Nikolac Perkovic, Matea, Maja Pucic Bakovic, Jasminka Kristic, et al. "The association between galactosylation of immunoglobulin G and body mass index." Progress in Neuro-Psychopharmacology and Biological Psychiatry 48 (January 2014): 20–25. http://dx.doi.org/10.1016/j.pnpbp.2013.08.014.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Anwar, Ali, Syed Uzair Ali Shah, Muhammad Naeem Rajput, Saeed Ahmed Soomro, and Atique Ahmed Behan. "Effects of Moringa oleifera leaf meal supplementation on growth performance and blood profiles of cattle heifers." World Journal of Biology and Biotechnology 9, no. 1 (2024): 25. http://dx.doi.org/10.33865/wjb.009.01.1183.

Pełny tekst źródła

Streszczenie:

To evaluate the impact of dietary inclusion of Moringa oleifera leaf meal (MOLM) on the growth performance, body conformation, and blood biochemistry of intensively managed cattle heifers, a total of 12 heifers were randomly selected and divided into two groups viz. group-CON (basal diet) and group-MOLM (basal diet + 10% Moringa oleifera leaf meal). Results indicate that significantly higher feed intake was observed in the MOLM group. The heifers supplemented with MOLM were having significantly improved body weight, body height, body length and heart girth compared to the heifers in CON group.

Style APA, Harvard, Vancouver, ISO itp.

22

Rosselli, Jennifer L., Stacey M. Thacker, Julie P. Karpinski, and Katherine A. Petkewicz. "Treatment of IgA Nephropathy: An Update." Annals of Pharmacotherapy 45, no. 10 (2011): 1284–96. http://dx.doi.org/10.1345/aph.1q122.

Pełny tekst źródła

Streszczenie:

Objective: To review current literature regarding treatment options for immunoglobulin A nephropathy (IgAN). Data Sources: A MEDLINE search was performed using the terms IgA nephropathy, Berger's disease, immunoglobulin A nephropathy, angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, fish oil, omega-3 fatty acids, statins. hydroxymethylglutaryl-CoA reductase Inhibitors, immunosuppressive therapy, corticosteroids, mycophenolate mofetil, cyclophosphamide, cyclosporine, azathioprine, leflunomide, antiplatelets, anticoagulants, vitamin E, infliximab, calcitriol, and intra

Style APA, Harvard, Vancouver, ISO itp.

23

Więsik-Szewczyk, Ewa, Aleksandra Kucharczyk, and Karina Jahnz-Różyk. "Current treatment options with immunoglobulin G for adult patients with primary immunodeficiency disease in Poland." Journal of Health Policy & Outcomes Research, no. 2 (December 31, 2014): 42–49. http://dx.doi.org/10.7365/jhpor.2014.2.5.

Pełny tekst źródła

Streszczenie:

Polyclonal immunoglobulin G life-long replacement is a corner stone therapy in patients with primary antibodies deficiency. The evidence of safety and effectiveness of IgG in PAD are strongly documented for reduction and protection for serious infections. There are still limited data for deletion from long term complications as progression of chronic lung diseases, bronchiectasis and damage. Nowadays accelerated progress in IgG products modulation and ways of administration allows for adjustment of this chronic treatment for patients needs and preferences, improving the patients’ compliances a

Style APA, Harvard, Vancouver, ISO itp.

24

Kimberly, Robert P., Jane E. Salmon, and Jeffrey C. Edberg. "Receptors for immunoglobulin g molecular diversity and implications for disease." Arthritis & Rheumatism 38, no. 3 (1995): 306–14. http://dx.doi.org/10.1002/art.1780380303.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Xuan, D., D. P. Nicolau, P. R. Tessier, L. Bow, R. Quintiliani, and C. H. Nightingale. "In vitro reduction of endotoxin concentrations with the 5S fragment of immunoglobulin G." Antimicrobial Agents and Chemotherapy 41, no. 7 (1997): 1512–16. http://dx.doi.org/10.1128/aac.41.7.1512.

Pełny tekst źródła

Streszczenie:

Endotoxin has long been implicated as an inducer for the development and progression of gram-negative sepsis. Accordingly, antiendotoxin therapy has been considered one of the major targets for the treatment of sepsis. To investigate the influence of a human immunoglobulin G (IgG) derivative, the 5S fragment of IgG (5S-IgG; Gamma-Venin, Centeon Pharma GmbH, Frankfurt-Niederrad, Germany), on endotoxin release during bacterial proliferation and under antibiotic bactericidal action, time-kill studies were performed by using Escherichia coli ATCC 25922 starting inocula of 10(3), 10(5), and 10(7) C

Style APA, Harvard, Vancouver, ISO itp.

26

SHIBAGUCHI, Hirotomo, Tomoka YAMAMOTO, Masahide KUROKI, and Koujiro FUTAGAMI. "Measurement and Assessment of Cytomegalovirus of Immunoglobulin (Ig) G Titer in Preparations." YAKUGAKU ZASSHI 130, no. 7 (2010): 977–82. http://dx.doi.org/10.1248/yakushi.130.977.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Ahn, Sang K., Yong K. Shin, Hee J. Kang, Eun S. Han, and Chung S. Lee. "Effects of protein kinase inhibitors on the stimulated neutrophil responses by degraded immunoglobulin G." European Journal of Pharmacology 306, no. 1-3 (1996): 175–80. http://dx.doi.org/10.1016/0014-2999(96)00097-0.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Christ, Torsten, Esther Adolph, Stefan Schindelhauer, et al. "Effects of Immunoglobulin G from Patients with Dilated Cardiomyopathy on Rat Cardiomyocytes." Basic Clinical Pharmacology Toxicology 96, no. 6 (2005): 445–52. http://dx.doi.org/10.1111/j.1742-7843.2005.pto_96607.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Andresen, Irmgard, John M. Kovarik, Martin Spycher, and Reinhard Bolli. "Product Equivalence Study Comparing the Tolerability, Pharmacokinetics, and Pharmacodynamics of Various Human Immunoglobulin-G Formulations." Journal of Clinical Pharmacology 40, no. 7 (2000): 722–30. http://dx.doi.org/10.1177/00912700022009477.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Hornby, Pamela J., Philip R. Cooper, Connie Kliwinski, et al. "Human and Non-Human Primate Intestinal FcRn Expression and Immunoglobulin G Transcytosis." Pharmaceutical Research 31, no. 4 (2013): 908–22. http://dx.doi.org/10.1007/s11095-013-1212-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Huda Sahib Al-Rawazq, Luay Ibraheem Al-Rawi, and Riyadh Abdul-R Al-Zubaidy. "Seroprevalence of celiac disease among children in Baghdad, Iraq." International Journal of Research in Pharmaceutical Sciences 12, no. 2 (2021): 954–57. http://dx.doi.org/10.26452/ijrps.v12i2.4609.

Pełny tekst źródła

Streszczenie:

Celiac disease (CD) represents A unique disorders in which consumption of a food ingredient namely gluten-containing grains (wheat, rye, barley) in combination with genetic susceptibility is fundamental for the development of an a guilefully evolving autoimmune reaction influence the gut and other organs. The present study determines the celiac disease among suspected children. From special the laboratory for Pathogenesis Analyses in Baghdad 100 blood children samples was collected during the period from 1st March 2018 till the 31 th of July 2018, analyzed by two serological test which were An

Style APA, Harvard, Vancouver, ISO itp.

32

Huda Sahib Al-Rawazq, Luay Ibraheem Al-Rawi, and Riyadh Abdul-R Al-Zubaidy. "Seroprevalence of celiac disease among children in Baghdad, Iraq." International Journal of Research in Pharmaceutical Sciences 11, SPL4 (2020): 2609–12. http://dx.doi.org/10.26452/ijrps.v11ispl4.4521.

Pełny tekst źródła

Streszczenie:

Celiac disease (CD) represents A unique disorders in which consumption of a food ingredient namely gluten-containing grains (wheat, rye, barley) in combination with genetic susceptibility is fundamental for the development of an a guilefully evolving autoimmune reaction influence the gut and other organs. The present study determines the celiac disease among suspected children. From special the laboratory for Pathogenesis Analyses in Baghdad 100 blood children samples was collected during the period from 1st March 2018 till the 31 th of July 2018, analyzed by two serological test which were An

Style APA, Harvard, Vancouver, ISO itp.

33

Lindsay, Christine A., Ken Dang, James M. Adams, Ching Nan Ou, and Carol J. Baker. "Stability and Activity of Intravenous Immunoglobulin with Neonatal Dextrose and Total Parenteral Nutrient Solutions." Annals of Pharmacotherapy 28, no. 9 (1994): 1014–17. http://dx.doi.org/10.1177/106002809402800902.

Pełny tekst źródła

Streszczenie:

OBJECTIVE: To determine in vitro the compatibility of reconstituted intravenous immunoglobulin (IVIG) (Gammagard, Baxter-Hyland) with five different neonatal and pediatric intravenous solutions in Viaflex polyvinyl chloride bags. DESIGN: In vitro compatibility study. INTERVENTIONS: Samples were taken at time=0, 10, 30, 60, 90, and 120 minutes and at 4, 8, 12, and 24 hours and assayed for total immunoglobulin G content and antibodies to hepatitis B surface antigen. Type III group B Streptococcus (GBS) and opsonic activity for type III GBS were analyzed at time=0, 60, and 120 minutes and 12 and

Style APA, Harvard, Vancouver, ISO itp.

34

Li, Zhaoyang, Kristin Follman, Ed Freshwater, Frank Engler, and Leman Yel. "Integrated population pharmacokinetics of immunoglobulin G following intravenous or subcutaneous administration of various immunoglobulin products in patients with primary immunodeficiencies." International Immunopharmacology 113 (December 2022): 109331. http://dx.doi.org/10.1016/j.intimp.2022.109331.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Li, Zhaoyang, Kristin Follman, Ed Freshwater, Frank Engler, and Leman Yel. "Population pharmacokinetics of immunoglobulin G after intravenous, subcutaneous, or hyaluronidase-facilitated subcutaneous administration in immunoglobulin-naive patients with primary immunodeficiencies." International Immunopharmacology 128 (February 2024): 111447. http://dx.doi.org/10.1016/j.intimp.2023.111447.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

Lee, Jian Lynn, Noraida Mohamed Shah, Mohd Makmor-Bakry, Farida Islahudin, Hamidah Alias, and Shamin Mohd Saffian. "A systematic review of population pharmacokinetic analyses of polyclonal immunoglobulin G therapy." International Immunopharmacology 97 (August 2021): 107721. http://dx.doi.org/10.1016/j.intimp.2021.107721.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Muratsugu, Makoto, Ayaka Yazawa, Sami Fujiwara, Satsuki Nishida, and Toru Fukui. "Quantitation of Biotin-Binding Immunoglobulins G, A, and M in Human Sera Using F(ab′)2Anti-human Immunoglobulin-Coated Microplates." Biological & Pharmaceutical Bulletin 31, no. 3 (2008): 507–10. http://dx.doi.org/10.1248/bpb.31.507.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Kruljec, Nika, Peter Molek, Vesna Hodnik, Gregor Anderluh, and Tomaž Bratkovič. "Development and Characterization of Peptide Ligands of Immunoglobulin G Fc Region." Bioconjugate Chemistry 29, no. 8 (2018): 2763–75. http://dx.doi.org/10.1021/acs.bioconjchem.8b00395.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Li, Danqi, Yuchen Lou, Yamin Zhang, Si Liu, Jun Li, and Juan Tao. "Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases." Theranostics 11, no. 11 (2021): 5430–46. http://dx.doi.org/10.7150/thno.53961.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Lavrnic, Dragana, Marija Romic, Aleksandra Kacar, et al. "High doses of immunoglobulin g in the therapy for severe forms of myasthenia gravis and Guillain-Barré syndrome." Vojnosanitetski pregled 63, no. 1 (2006): 37–42. http://dx.doi.org/10.2298/vsp0601037l.

Pełny tekst źródła

Streszczenie:

Background/Aim. High doses of immunoglobulin G (IVIG) have been recognized as a very important therapeutic modality in the treatment of neurological diseases. The aim of this report was to present our experience in the treatment of severe forms of myasthenia gravis (MG) and Guillain-Barr? syndrome (GBS). Methods. We analyzed the efficacy and safety of immunoglobulin G therapy in 53 patients with severe forms of myasthenia gravis, and 27 patients with very severe forms of Guillain-Barr? syndrome. Results. At the end of the follow-up period, a significant improvement was noticed in 47 out of 53

Style APA, Harvard, Vancouver, ISO itp.

41

Balkovic, Edward S., James A. Florack, and Howard R. Six. "Immunoglobulin G subclass antibody responses of mice to influenza virus antigens given in different forms." Antiviral Research 8, no. 3 (1987): 151–60. http://dx.doi.org/10.1016/0166-3542(87)90068-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Cn, Hemalatha, Vijey Aanandhi M, and Vijey Aanandhi M. "G-QUADRUPLEX LIGANDS AS STABILIZER TARGETING TELOMERASE ENZYME AS ANTI CANCER AGENTS." Asian Journal of Pharmaceutical and Clinical Research 10, no. 8 (2017): 50. http://dx.doi.org/10.22159/ajpcr.2017.v10i8.19797.

Pełny tekst źródła

Streszczenie:

The human telomere stabilization with G-Quadruplex DNA tends to induce apoptosis. The molecular target of telomere cascade with a rigid molecular may show efficacious to treat cancer. The study of intercalation to human telomeric DNA with proposed ligand can be evaluated by the help of biophysical studies and biological studies. G-Quadruplex is one of the key epigenetic episodes of eukaryotes and prokaryotes, generally found in the telomeric end region, immunoglobulin switch recombination and the lagging strand of the DNA. These chemotherapeutic advances are not enough to maintain a life expec

Style APA, Harvard, Vancouver, ISO itp.

43

MIMURA, Tsutomu, Masaaki ITOH, Tetsuya SUGIYAMA, et al. "Studies on Pharmacological Activation of Human Immunoglobulin G by Chemical Modification and Active Subfragments. X. Effect of Carboxamidemethylated Fc Fragment (CM-Fc) from Human Immunoglobulin G on Delayed Type Hypersensitivity." Biological & Pharmaceutical Bulletin 16, no. 9 (1993): 858–60. http://dx.doi.org/10.1248/bpb.16.858.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

MIMURA, Tsutomu, Masaaki ITOH, Tetsuya SUGIYAMA, et al. "Studies on Pharmacological Activation of Human Immunoglobulin G by Chemical Modification and Active Subfragments. XII. Effect of Carboxamidemethylated Fc Fragment (CM-Fc) from Human Immunoglobulin G on Mixed Lymphocyte Reaction." Biological & Pharmaceutical Bulletin 17, no. 3 (1994): 411–14. http://dx.doi.org/10.1248/bpb.17.411.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Mushcab, Hayat, Jaffar A. Al-Tawfiq, Amani Babgi, et al. "Longevity of Immunoglobulin-G Antibody Response Against Nucleocapsid Protein Against SARS-CoV-2 Among Healthcare Workers." Infection and Drug Resistance Volume 16 (May 2023): 3407–16. http://dx.doi.org/10.2147/idr.s400365.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Liu, Di, Qihuan Li, Jing Dong, et al. "The Association Between Normal BMI With Central Adiposity And Proinflammatory Potential Immunoglobulin G N-Glycosylation." Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Volume 12 (November 2019): 2373–85. http://dx.doi.org/10.2147/dmso.s216318.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Paula, Nigella, Marcelo Conzentino, Ana Gonçalves, et al. "Population-Based Analysis of the Immunoglobulin G Response to Different COVID-19 Vaccines in Brazil." Vaccines 11, no. 1 (2022): 21. http://dx.doi.org/10.3390/vaccines11010021.

Pełny tekst źródła

Streszczenie:

(1) Background: COVID-19 vaccination in Brazil has been performed mostly with CoronaVac (Sinovac), ChAdOx1-S (AstraZeneca-University of Oxford) and BNT162b2 (Pfizer-BioNTech) vaccines. The titers of IgG antibodies reactive to the SARS-CoV-2 spike protein correlate with vaccine efficacy. Studies comparing vaccine immunogenicity in a real-world scenario are lacking. (2) Methods: We performed a population-based study to analyze the immunoglobulin G response to different COVID-19 vaccines. Citizens older than 18 years (n = 2376) provided personal data, a self-declaration of any previous COVID-19 p

Style APA, Harvard, Vancouver, ISO itp.

48

He, Qing, Yejian Wu, Shuiping Hou, Lei Luo, and Zhoubin Zhang. "Seroprevalence of Diphtheria and Tetanus Immunoglobulin G among the General Health Population in Guangzhou, China." Vaccines 12, no. 4 (2024): 381. http://dx.doi.org/10.3390/vaccines12040381.

Pełny tekst źródła

Streszczenie:

A seroepidemiological study was conducted in 2018 to assess diphtheria and tetanus antibodies in Guangzhou, China. Diphtheria and tetanus antibody concentrations were measured with an enzyme-linked immunosorbent assay. A total of 715 subjects were enrolled in the study. The overall diphtheria and tetanus toxoid IgG-specific antibody levels were 0.126 IU/mL (95% CI: 0.115, 0.137) and 0.210 IU/mL (95% CI: 0.185, 0.240), respectively; the overall positivity rate was 61.82% (95% CI: 58.14, 65.39) and 71.61% (95% CI: 68.3, 74.92), respectively. The diphtheria and tetanus antibody concentration was

Style APA, Harvard, Vancouver, ISO itp.

49

Salmon, Jane E., and Luminita Pricop. "Human receptors for immunoglobulin G: Key elements in the pathogenesis of rheumatic disease." Arthritis & Rheumatism 44, no. 4 (2001): 739–50. http://dx.doi.org/10.1002/1529-0131(200104)44:4<739::aid-anr129>3.0.co;2-o.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Okuda, Sachio, Shintaro Kamei, and Takumi Sasaki. "Immunoglobulin G Enhances Generation of Inducible T Regulatory Cells and Increases Their Regulatory Function." Biological and Pharmaceutical Bulletin 41, no. 12 (2018): 1830–36. http://dx.doi.org/10.1248/bpb.b18-00548.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!